Tissue engineering is a promising new approach for the repair of articular cartilage defects. However, it has been challenging to produce enough tissue from the limited number of cells that can be reasonably extracted from a single individual. Several different approaches have been taken to stimulate the production of cartilaginous extracellular matrix (ECM), such as gene therapy [1] and stimulation by growth factors [2] and/or mechanical loading [3]. Alternatively, there are relatively few methods available to reliably increase the population of cells needed for this approach without the elicitation negative sideeffects such as the dedifferentiation and loss of potency observed during cell expansion [4]. A single modulator of chondrocyte function, such as the C-type natriuretic peptide (CNP), may serve to simultaneously address both of these issues. CNP, the third member of the natriuretic peptide family, is a positive regulator of endochondral ossification which is expressed in growth-plate cartilage and involved in the regulation of both chondrocyte proliferation and differentiation [5] . Thus, stimulation of tissue-engineered cartilage with natriuretic peptides may potentially serve to simultaneously modulate both proliferation and extracellular matrix (ECM) deposition. The purpose of this study was to determine the functionality of articular chondrocyte natriuretic peptide surface receptors and the effect of long-term natriuretic peptide stimulation on cartilaginous tissue formed in vitro.
INTRODUCTION
Tissue engineering is a promising new approach for the repair of articular cartilage defects. However, it has been challenging to produce enough tissue from the limited number of cells that can be reasonably extracted from a single individual. Several different approaches have been taken to stimulate the production of cartilaginous extracellular matrix (ECM), such as gene therapy [1] and stimulation by growth factors [2] and/or mechanical loading [3] . Alternatively, there are relatively few methods available to reliably increase the population of cells needed for this approach without the elicitation negative sideeffects such as the dedifferentiation and loss of potency observed during cell expansion [4] . A single modulator of chondrocyte function, such as the C-type natriuretic peptide (CNP), may serve to simultaneously address both of these issues. CNP, the third member of the natriuretic peptide family, is a positive regulator of endochondral ossification which is expressed in growth-plate cartilage and involved in the regulation of both chondrocyte proliferation and differentiation [5] . Thus, stimulation of tissue-engineered cartilage with natriuretic peptides may potentially serve to simultaneously modulate both proliferation and extracellular matrix (ECM) deposition. The purpose of this study was to determine the functionality of articular chondrocyte natriuretic peptide surface receptors and the effect of long-term natriuretic peptide stimulation on cartilaginous tissue formed in vitro.
MATERIALS AND METHODS
Cell Isolation: Primary chondrocytes were isolated from the calf (12-18 months in age) metacarpal-carpal articular cartilage by sequential enzymatic digestion. Receptor Binding Assays: Functionality of the chondrocyte natriuretic peptide surface receptors were determined using competitive binding assays. Primary cells were cultured in monolayer using serum-free RPMI media with 0.1% BSA, grown to 90% confluence and binding assays were initiated by the addition of 125 I-labeled atrial natriuretic peptide (ANP). Assay was conducted either in the presence of 1 µM C-ANP[4-23] (American Peptide Inc.) to block binding to NPRC (CNP receptor or clearance receptor) and thus determine binding to NPRA and NPRB (receptors for both ANP and BNP) or 1 µM human ANP to determine non-specific binding. Binding assays were performed at 4°C for 60 min after which the cultures were washed three-times with PBS and harvested by adding 0.075% trypsin-EDTA. Detached cells and supernatants were counted using a gamma counter. Formation of Cartilaginous Tissue In Vitro: Primary articular chondrocytes were seeded on collagen-II coated Millipore™ filters (25,000 cells/mm 2 ) [6] . The cells were incubated at 37°C and 5% CO2 in Ham's F-12 medium supplemented with 20% FBS, 25 mM HEPES and 100 µg/mL ascorbate. Logarithmically increasing doses of CNP were added to the culture media ranging from 10 pM to 10 nM. Control cultures were supplemented with the same volume of vehicle (0.1 N acetic acid). Media was changed every 2-3 days with both the ascorbate and CNP added fresh at each change. Cultures were maintained for four weeks and harvested for evaluation. ECM Accumulation after Long-Term Culture: The tissue that had accumulated on the Millipore filters was weighed (wet weight) and then digested by papain (40 µg/mL in 20 mM ammonium acetate, 1 mM EDTA, and 2 mM DTT) for 48 hours at 65°C. Aliquots of the digest were assayed for the contents of DNA (Hoechst 33258 dye binding assay and fluorometry), sulphated glycosaminoglycans as a marker for proteoglycans (dimethylmethylene blue dye binding assay and spectrophotometry) and hydroxyproline as an marker for collagen (chloramine-T/Ehlrich's reagent dye binding and spectrophotometry). Statistics: All results were compared statistically amongst the loading conditions using a one-way ANOVA and the Fisher's LSD post-hoc test. Significance was assigned at p-values less than 0.05.
RESULTS
The functionality of articular chondrocyte natriuretic peptide surface receptors was determined using competitive binding assays in monolayer. Majority of the binding was observed to NPRC with very little (5%) binding to the NPRA and NPRB (Figure 1a) , suggesting that the NPRC is the predominant natriuretic peptide receptor on the surface of monolayer articular chondrocytes. The competitive binding curve of the receptors (Figure 1b ) revealed dose-dependent binding up to 10 nM (10 -8 M) concentration.
Figure 1: Functionality of Natriuretic Peptide Receptors
To determine the long-term effect of natriuretic peptide stimulation on the growth of cartilaginous tissue formed in vitro, isolated articular chondrocytes were seeded in 3D culture supplemented with varying doses of CNP (10 pM to 10 nM) for a period of four-weeks. Stimulation with CNP revealed differential effects at low versus high concentrations of the peptide. Low doses of CNP appeared to preferentially stimulate chondrocyte proliferation with no apparent effect on ECM accumulation. The maximal increase in cellularity occurred at 100 pM (43% over control, p<0.05) ( Table 1) . Alternatively, high doses of CNP resulted in increased ECM accumulation without an observed increase in cellularity. Maximal response of increased matrix deposition was observed at 10 nM with a 36% and 137% increase (relative to control, p<0.05) in the accumulation of proteoglycans and collagen, respectively (Table 1) . 
DISCUSSION
Stimulation of tissue-engineered cartilage with natriuretic peptides had a profound affect on both the growth and maturation of the developed tissue. Cultured articular chondrocytes appeared to display NPRC and when stimulated with the C-type natriuretic peptide (CNP) over the long-term, differential effects were observed. Low concentrations of CNP tended to favour chondroycyte proliferation whereas higher concentrations of CNP stimulated the deposition of cartilaginous extracellular matrix (ECM). Interestingly, under these conditions the effect on collagen accumulation was several times greater (over 3-fold) than proteoglycan accumulation which is very promising since it has proved difficult to accumulate collagen in sufficient quantities [7] . These observations were markedly similar to the previously reported effects of CNP on growth-plate cartilage, affecting both chondrocyte proliferation and differentiation [5] . Thus, by stimulating cultured chondrocytes with different doses of CNP, it may be possible to produce enough tissue from the limited number of cells that can be reasonably extracted from a single individual for therapeutic purposes.
